Compound Q&A
What is the market or research trend for Bedaquiline Fumarate (CAS: 845533-86-0)?
Answer
The market for Bedaquiline Fumarate (CAS: 845533-86-0) is driven by its critical role in the treatment of multidrug-resistant tuberculosis. Research trends are focused on improving its efficacy, developing new formulations, and exploring its potential in combination therapies. Additionally, there is ongoing interest in understanding its mechanism of action and identifying biomarkers for patient response.
About
CAS No
845533-86-0
English Name
Bedaquiline Fumarate
Molecular Formula
C36H35BrN2O6
Molecular Weight
671.59 g/mol
SMILES
CN(C)CC[C@@](c1cccc2c1cccc2)([C@H](c3ccccc3)c4cc5cc(ccc5nc4OC)Br)O.C(=C/C(=O)O)\C(=O)O
InChIKey
ZLVSPMRFRHMMOY-WWCCMVHESA-N
Last Updated: 2025-09-21 10:38
